ÂÜÀòÂÒÂ×

Mr. Elam has served as a member of Savara’s Board of Directors since February 2009. He is currently a member of the Board of Directors and the President and Chief Executive Officer of Rezolute, Inc., a biopharmaceutical company focused on developing therapies for metabolic diseases with serious unmet needs. Prior to his tenure at Rezolute, Mr. Elam held senior executive roles within the pharmaceutical industry, including Senior Vice President and Head of the Pulmonary business unit of Nektar Therapeutics and President and Chief Executive Officer of a European medical device company. Earlier in his career, Mr. Elam was Co-Founder and Chief Financial Officer of E2open, Inc. and a partner in the corporate practice of the law firm of Wilson Sonsini Goodrich & Rosati, P.C. Mr. Elam holds a J.D. from Harvard Law School and a B.A. from Howard University.